The delivery system was found to be effective in targeting the CAFs, as evidenced by increased G0/G1 phase arrest of CAFs, inhibition of tumor cell migration, and downregulation of several cytokines involved in cell proliferation, angiogenesis, and cell migration. This evidence concerns the gene TBX1 and neoplasm.